Literature DB >> 16493001

False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise.

Monique Beullens1, Joris R Delanghe, Mathieu Bollen.   

Abstract

Erythropoietin (Epo) is a glycoprotein hormone that promotes the production of red blood cells. Recombinant human Epo (rhEpo) is illicitly used to improve performance in endurance sports. Doping in sports is discouraged by the screening of athletes for rhEPO in urine. The adopted test is based on a combination of isoelectric focusing and double immunoblotting, and distinguishes between endogenous and recombinant human Epo. We show here that this widely used test can occasionally lead to the false-positive detection of rhEpo (epoetin-beta) in postexercise, protein-rich urine, probably because the adopted monoclonal anti-Epo antibodies are not monospecific.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16493001     DOI: 10.1182/blood-2006-01-0028

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

Review 1.  [Doping. High-tech cheating in sport].

Authors:  H Striegel; P Simon
Journal:  Internist (Berl)       Date:  2007-07       Impact factor: 0.743

2.  It is not hypoxia itself, but how you use it.

Authors:  Fabian Sanchis-Gomar; Vladimir E Martinez-Bello; Mari Carmen Gomez-Cabrera; Jose Viña
Journal:  Eur J Appl Physiol       Date:  2010-01-01       Impact factor: 3.078

3.  Screening for recombinant human erythropoietin using [Hb], reticulocytes, the OFF(hr score), OFF(z score) and Hb(z score): status of the Blood Passport.

Authors:  Andreas Bornø; Niels J Aachmann-Andersen; Thor Munch-Andersen; Carl J Hulston; Carsten Lundby
Journal:  Eur J Appl Physiol       Date:  2010-02-02       Impact factor: 3.078

4.  Effect of intermittent hypoxia on hematological parameters after recombinant human erythropoietin administration.

Authors:  F Sanchis-Gomar; V E Martinez-Bello; E Domenech; A L Nascimento; F V Pallardo; Mari Carmen Gomez-Cabrera; J Vina
Journal:  Eur J Appl Physiol       Date:  2009-08-08       Impact factor: 3.078

Review 5.  Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.

Authors:  S Elliott
Journal:  Br J Pharmacol       Date:  2008-03-24       Impact factor: 8.739

6.  Current anti-doping policy: a critical appraisal.

Authors:  Bengt Kayser; Alexandre Mauron; Andy Miah
Journal:  BMC Med Ethics       Date:  2007-03-29       Impact factor: 2.652

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.